Receive our newsletter – data, insights and analysis delivered to you
March 4, 2010

Johns Hopkins Scanner Spots Melanoma Early

A non-invasive infrared scanning system that will help doctors determine whether pigmented skin growths are benign moles or melanoma has been developed by US researchers. According to Johns Hopkins researchers, the system works by looking for the tiny temperature difference between heal

By cms admin

A non-invasive infrared scanning system that will help doctors determine whether pigmented skin growths are benign moles or melanoma has been developed by US researchers.

According to Johns Hopkins researchers, the system works by looking for the tiny temperature difference between healthy tissue and a growing tumour.

Because cancer cells divide more rapidly than normal cells, they typically generate more metabolic activity and release more energy as heat. The temperature difference, however, is extremely small. To detect this, the scientists first cool a patient’s skin with a harmless one-minute burst of compressed air.

When the cooling is stopped, scientists immediately record infrared images of the target skin area for two to three minutes. Cancer cells typically reheat more quickly than the surrounding healthy tissue, and this difference can be captured by the infrared camera and viewed through sophisticated image processing.

The researchers are also hopeful that the handheld scanning system, which has begun testing on a pilot study of 50 patients at Johns Hopkins, might also be incorporated into a full-body scanning system for patients with a large number of pigmented lesions.

Johns Hopkins’ Whiting School of Engineering professor of mechanical engineering Cila Herman said that there is a lot of work to do with the system.

Content from our partners
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
The powerful networks advancing life sciences in Charleston | USA
The power of infrastructure: How Charleston | SC | USA is expanding horizons for life science companies

“We need to fine-tune the scanning system and the software and develop diagnostic criteria for cancerous lesions to find melanoma at an early stage before it spreads and becomes dangerous to the patient,” Herman said.

There were 68,720 new cases of melanoma reported in the US in 2009, and 8,65 deaths from the disease, according to the National Cancer Institute.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Get important industry news and analysis sent to your inbox
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU